Tower Research Capital (TRC)’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,453
Closed -$7K 6639
2022
Q4
$7K Sell
15,453
-22,853
-60% -$10.4K ﹤0.01% 4666
2022
Q3
$11K Buy
38,306
+3,292
+9% +$945 ﹤0.01% 4497
2022
Q2
$13K Buy
35,014
+26,752
+324% +$9.93K ﹤0.01% 4255
2022
Q1
$6K Sell
8,262
-3,811
-32% -$2.77K ﹤0.01% 4980
2021
Q4
$16K Buy
12,073
+2,811
+30% +$3.73K ﹤0.01% 3959
2021
Q3
$20K Buy
9,262
+9,161
+9,070% +$19.8K ﹤0.01% 3737
2021
Q2
$0 Sell
101
-3,978
-98% ﹤0.01% 6044
2021
Q1
$11K Sell
4,079
-14,227
-78% -$38.4K ﹤0.01% 4337
2020
Q4
$51K Buy
18,306
+18,291
+121,940% +$51K ﹤0.01% 3115
2020
Q3
$0 Sell
15
-850
-98% ﹤0.01% 5213
2020
Q2
$2K Buy
865
+399
+86% +$923 ﹤0.01% 4556
2020
Q1
$1K Sell
466
-4,937
-91% -$10.6K ﹤0.01% 2890
2019
Q4
$28K Buy
5,403
+2,166
+67% +$11.2K ﹤0.01% 1722
2019
Q3
$20K Sell
3,237
-984
-23% -$6.08K ﹤0.01% 2488
2019
Q2
$27K Buy
4,221
+4,171
+8,342% +$26.7K ﹤0.01% 1981
2019
Q1
$1K Sell
50
-432
-90% -$8.64K ﹤0.01% 3665
2018
Q4
$4K Sell
482
-1,038
-68% -$8.61K ﹤0.01% 3099
2018
Q3
$29K Sell
1,520
-6,247
-80% -$119K ﹤0.01% 2107
2018
Q2
$141K Buy
7,767
+7,317
+1,626% +$133K 0.01% 1232
2018
Q1
$4K Buy
450
+390
+650% +$3.47K ﹤0.01% 2819
2017
Q4
$3K Sell
60
-138
-70% -$6.9K ﹤0.01% 3132
2017
Q3
$11K Buy
+198
New +$11K ﹤0.01% 3043
2017
Q1
Sell
-19
Closed -$2K 4159
2016
Q4
$2K Sell
19
-559
-97% -$58.8K ﹤0.01% 3496
2016
Q3
$65K Buy
578
+553
+2,212% +$62.2K 0.01% 1008
2016
Q2
$3K Buy
25
+10
+67% +$1.2K ﹤0.01% 3768
2016
Q1
$1K Sell
15
-121
-89% -$8.07K ﹤0.01% 3851
2015
Q4
$20K Buy
136
+27
+25% +$3.97K ﹤0.01% 1310
2015
Q3
$11K Buy
109
+45
+70% +$4.54K ﹤0.01% 2261
2015
Q2
$10K Buy
+64
New +$10K ﹤0.01% 2727